AMAbdulrahmon Mbbs Moradeyo

Abdulrahmon Mbbs Moradeyo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdulrahmon Mbbs Moradeyo has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A review of proton beam therapy’s role in glioma management

    by Nicholas Mbbs Aderinto, Gbolahan Mbbs Olatunji, Emmanuel Mbbs Kokori, Doyin Olatunji, Oluwatobi Mbbs Omoworare, Adetola Emmanuel Mds Babalola, Chimezirim Mbbs Ezeano, Damilare Adewale Mbbs Olusanya, David Timilehin Mbbs Isarinade, Aminat Mbbs Akinoso, et al.

    Gliomas pose significant therapeutic challenges due to limited survival and risks of treatment-related toxicity. Proton beam therapy (PBT) offers a precise radiation delivery method, minimizing damage to healthy brain tissue compared to conventional radiotherapy. This review synthesizes findings from 15 studies (2000–January 2024) from PubMed, Google Scholar, Science Direct, Cochrane Library, and Directory of Open Access Journals. PBT significantly reduces neurocognitive decline and enhances quality of life while achieving comparable or superior survival outcomes across various glioma types, including low-grade gliomas and glioblastomas. Notable benefits include improved verbal memory, stable intellectual functioning, and reduced high-grade toxicity. However, challenges such as neuroendocrine deficiencies and increased radiation necrosis highlight the need for optimized protocols. Future research should focus on comprehensive outcome assessments, proactive management of adverse effects, and improving PBT accessibility through cost reduction and technological advancements. PBT holds transformative potential in glioma management, balancing effective tumor control with preservation of neurological function, positioning it as a valuable neuro-oncology treatment option.


  • Revolutionizing Cardiac Care: Artificial Intelligence Applications in Heart Failure Management

    by Areeba Mbbs Fareed, Rayyan Mbbs Vaid, Abdulrahmon Mbbs Moradeyo, Afra Mbbs Sohail, Ayesha Mbbs Sarwar, Aashar Mbbs Khalid

    Recent advancements in artificial intelligence (AI) have revolutionized the diagnosis, risk assessment, and treatment of heart failure (HF). AI models have demonstrated superior performance in distinguishing healthy individuals from those at risk of congestive HF by analyzing heart rate variability data. In addition, AI clinical decision support systems exhibit high concordance rates with HF experts, enhancing diagnostic precision. For HF with reduced as well as preserved ejection fraction, AI-powered algorithms help detect subtle irregularities in electrocardiograms and other related predictors. AI also aids in predicting HF risk in diabetic patients, using complex data patterns to enhance understanding and management. Moreover, AI technologies help forecast HF-related hospital admissions, enabling timely interventions to reduce readmission rates and improve patient outcomes. Continued innovation and research are crucial to address challenges related to data privacy and ethical considerations and ensure responsible implementation in healthcare.


  • Open Access

    Understanding the biological effects of hypoxia in ischemic stroke: implications for rehabilitation and recovery

    by Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Bonaventure Ukoaka, Adetola Emmanuel Babalola, Ikponmwosa Jude Ogieuhi, Abdulrahmon Moradeyo, Ismaila Ajayi Yusuf, Apampa Oluwatobiloba Oluwatomisin, Adefusi Temiloluwa Oluwakorede, et al.


  • Open Access

    Expanding surgical access in Africa through improved health insurance schemes: A review

    by Nicholas Mbbs Aderinto, Gbolahan Mbbs Olatunji, Emmanuel Mbbs Kokori, Moradeyo Akanmu Mbbs Abdulrahmon, Ayodeji Mbbs Akinmeji, John Oluwasegun Mbbs Fatoye

    Surgical access remains a pressing public health concern in African nations, with a substantial portion of the population facing challenges in obtaining safe, timely, and affordable surgical care. This paper delves into the impact of health insurance schemes on surgical accessibility in Africa, exploring the barriers, challenges, and future directions. It highlights how high out-of-pocket costs, reliance on traditional healing practices, and inadequate surgical infrastructure hinder surgical utilization. Financing mechanisms often need to be more effective, and health insurance programs face resistance within the informal sector. Additionally, coverage of the poor remains a fundamental challenge, with geographical and accessibility barriers compounding the issue. Government policies, often marked by inconsistency and insufficient allocation of resources, create further obstacles. However, strategic purchasing and fund integration offer avenues for improving the efficiency of health insurance programs. The paper concludes by offering policy recommendations, emphasizing the importance of inclusive policies, streamlined financing mechanisms, coverage expansion, and enhanced strategic purchasing to bridge the surgical access gap in Africa. Decoupling entitlement from the payment of contributions, broadening the scope of coverage for outpatient medicines and related expenses, and enhancing safeguards against overall costs and charges, especially for individuals with lower incomes. Ultimately, by addressing these challenges and harnessing the potential of health insurance schemes, the continent can move closer to achieving universal surgical care and improving the well-being of its people.